Massive Parallel Current Power Amplifier Concept for Power Hardware in the Loop Applications

The development of the smartgrid increases the complexity of the current electric grid. To verify and validate the operation of the systems involved in it, Power Hardware-In-theLoop (PHIL) technique allows to test the complete system in an exhaustive way. But the reduced bandwidth of the overall test system can cause inaccuracies and instabilities, which can be harmful for the Hardware Under Test (HUT) or the people who are performing the test. To increase PHIL performance and tackle these problems, this paper proposes a new concept of high bandwidth current amplifier. It is based on a topology of massive parallel interleaved buck-boost converter, which distribute in an equal manner the total current in all the branches. This current reduction allows to use transistors with better switching behaviour, which increase the bandwidth of the converter. Furthermore, a Discontinuous Conduction Mode (DCM) is used, obtaining the nominal output current in only one switching cycle. Description of the concept and the design parameters are provided. Finally, the behaviour of the proposed Power Amplifier (PA) at high frequency setpoint currents is shown in a Matlab/Simulink simulation. © 2022, European Association for the Development of Renewable Energy, Environment and Power Quality (EA4EPQ). All rights reserved

Optimal d-statcom placement tool for low voltage grids

In low-voltage grids with a wide spread of domestic and/or small commercial consumers, mostly single-phase, problems can appear due to unbalanced power consumption between the different phases. These problems are mainly caused due to voltage unbalances between phases and the increase in distribution losses. This phenomenon occurs more frequently at the end of highly radial grids and can be stressed by the installation of renewable generators next to the consumers. Amongst the various techniques that have been proposed to solve this problem, this article explores the use of a D-STATCOM, presenting and testing a new method for the optimal location of this type of D-FACT. The developed method starts from a detailed analysis of the existing voltage unbalances in a distribution network and identifies the optimal location of the D-STATCOM (i.e., the one that reduces these unbalances while reducing energy losses). The developed method has been successfully tested for one year at four real European locations with different characteristics and different kinds of users. © 2021 by the authors. Licensee MDPI, Basel, Switzerland

Novel utility-scale photovoltaic plant electroluminescence maintenance technique by means of bidirectional power inverter controller

Nowadays, photovoltaic (PV) silicon plants dominate the growth in renewable energies generation. Utility-scale photovoltaic plants (USPVPs) have increased exponentially in size and power in the last decade and, therefore, it is crucial to develop optimum maintenance techniques. One of the most promising maintenance techniques is the study of electroluminescence (EL) images as a complement of infrared thermography (IRT) analysis. However, its high cost has prevented its use regularly up to date. This paper proposes a maintenance methodology to perform on-site EL inspections as efficiently as possible. First, current USPVP characteristics and the requirements to apply EL on them are studied. Next, an increase over the automation level by means of adding automatic elements in the current PV plant design is studied. The new elements and their configuration are explained, and a control strategy for applying this technique on large photovoltaic plants is developed. With the aim of getting on-site EL images on a real plant, a PV inverter has been developed to validate the proposed methodology on a small-scale solar plant. Both the electrical parameters measured during the tests and the images taken have been analysed. Finally, the implementation cost of the solution has been calculated and optimised. The results conclude the technical viability to perform on-site EL inspections on PV plants without the need to measure and analyse the panel defects out of the PV installation

Manejo de la inmunosupresión en pacientes trasplantados de riñón con COVID19. Estudio multicéntrico nacional derivado del registro COVID de la Sociedad Española de Nefrología

Introduction: SARS CoV2 infection has had a major impact on renal transplant patients with a high mortality in the first months of the pandemic. Intentional reduction of immunosuppressive therapy has been postulated as one of the cornerstone in the management of the infection in the absence of targeted antiviral treatment. This has been modified according to the patient`s clinical situation and its effect on renal function or anti-HLA antibodies in the medium term has not been evaluated.Objectives: Evaluate the management of immunosuppressive therapy made during SARS-CoV2 infection, as well as renal function and anti-HLA antibodies in kidney transplant patients 6 months after COVID19 diagnosis.Material and methods: Retrospective, national multicentre, retrospective study (30 centres) of kidney transplant recipients with COVID19 from 01/02/20 to 31/12/20. Clinical variables were collected from medical records and included in an anonymised database. SPSS statistical software was used for data analysis.Results: renal transplant recipients with COVID19 were included (62.6% male), with a mean age of 57.5 years. The predominant immunosuppressive treatment prior to COVID19 was triple therapy with prednisone, tacrolimus and mycophenolic acid (54.6%) followed by m-TOR inhibitor regimens (18.6%). After diagnosis of infection, mycophenolic acid was discontinued in 73.8% of patients, m-TOR inhibitor in 41.4%, tacrolimus in 10.5% and cyclosporin A in 10%. In turn, 26.9% received dexamethasone and 50.9% were started on or had their baseline prednisone dose increased. Mean creatinine before diagnosis of COVID19, at diagnosis and at 6 months was: 1.7 +/- 0.8, 2.1 +/- 1.2 and 1.8 +/- 1 mg/dl respectively (p < 0.001). 56.9% of the patients (N = 350) were monitored for anti-HLA antibodies. 94% (N = 329) had no anti-HLA changes, while 6% (N = 21) had positive anti-HLA antibodies. Among the patients with donor-specific antibodies post-COVID19 (N = 9), 7 patients (3.1%) had one immunosuppressant discontinued (5 patients had mycophenolic acid and 2 had tacrolimus), 1 patient had both immunosuppressants discontinued (3.4%) and 1 patient had no change in immunosuppression (1.1%), these differences were not significant.Conclusions: The management of immunosuppressive therapy after diagnosis of COVID19 was primarily based on discontinuation of mycophenolic acid with very discrete reductions or discontinuations of calcineurin inhibitors. This immunosuppression management did not influence renal function or changes in anti-HLA antibodies 6 months after diagnosis

Tratamientos psicológicos empíricamente apoyados para adultos: Una revisión selectiva

Antecedentes: los tratamientos psicológicos han mostrado su eficacia, efectividad y eficiencia para el abordaje de los trastornos mentales; no obstante, considerando el conocimiento científico generado en los últimos años, no se dispone de trabajos de actualización en español sobre cuáles son los tratamientos psicológicos con respaldo empírico. El objetivo fue realizar una revisión selectiva de los principales tratamientos psicológicos empíricamente apoyados para el abordaje de trastornos mentales en personas adultas. Método: se recogen niveles de evidencia y grados de recomendación en función de los criterios propuestos por el Sistema Nacional de Salud de España (en las Guías de Práctica Clínica) para diferentes trastornos psicológicos. Resultados: los resultados sugieren que los tratamientos psicológicos disponen de apoyo empírico para el abordaje de un amplio elenco de trastornos psicológicos. El grado de apoyo empírico oscila de bajo a alto en función del trastorno psicológico analizado. La revisión sugiere que ciertos campos de intervención necesitan una mayor investigación. Conclusiones: a partir de esta revisión selectiva, los profesionales de la psicología podrán disponer de información rigurosa y actualizada que les permita tomar decisiones informadas a la hora de implementar aquellos procedimientos psicoterapéuticos empíricamente fundamentados en función de las características de las personas que demandan ayuda. Background: Psychological treatments have shown their efficacy, effectiveness, and efficiency in dealing with mental disorders. However, considering the scientific knowledge generated in recent years, in the Spanish context, there are no updating studies about empirically supported psychological treatments. The main goal was to carry out a selective review of the main empirically supported psychological treatments for mental disorders in adults. Method: Levels of evidence and degrees of recommendation were collected based on the criteria proposed by the Spanish National Health System (Clinical Practice Guidelines) for different psychological disorders. Results: The results indicate that psychological treatments have empirical support for the approach to a wide range of psychological disorders. These levels of empirical evidence gathered range from low to high depending on the psychological disorder analysed. The review indicates the existence of certain fields of intervention that need further investigation. Conclusions: Based on this selective review, psychology professionals will be able to have rigorous, up-to-date information that allows them to make informed decisions when implementing empirically based psychotherapeutic procedures based on the characteristics of the people who require help